The estimated Net Worth of Walter C Herlihy is at least 48.9 百万$ dollars as of 12 May 2015. Walter Herlihy owns over 45,431 units of Repligen stock worth over 37,632,462$ and over the last 21 years Walter sold RGEN stock worth over 11,308,799$.
Walter has made over 21 trades of the Repligen stock since 2005, according to the Form 4 filled with the SEC. Most recently Walter sold 45,431 units of RGEN stock worth 1,770,446$ on 12 May 2015.
The largest trade Walter's ever made was exercising 243,723 units of Repligen stock on 13 July 2007 worth over 343,649$. On average, Walter trades about 50,314 units every 133 days since 2004. As of 12 May 2015 Walter still owns at least 262,430 units of Repligen stock.
You can see the complete history of Walter Herlihy stock trades at the bottom of the page.
Walter's mailing address filed with the SEC is C/O REPLIGEN CORPORATION, 41 SEYON STREET SUITE 100, BUILDING 1, WALTHAM, MA, 02453.
Over the last 22 years, insiders at Repligen have traded over 118,224,292$ worth of Repligen stock and bought 160,440 units worth 1,459,521$ . The most active insiders traders include Partners L P/Ilbiotechnolog...、Glenn P Muir、Walter C Herlihy. On average, Repligen executives and independent directors trade stock every 33 days with the average trade being worth of 3,015,702$. The most recent stock trade was executed by Ralf Kuriyel on 2 August 2024, trading 7,148 units of RGEN stock currently worth 1,139,034$.
repligen corporation is a life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. we are a leading manufacturer of protein a, a critical reagent used to manufacture monoclonal antibody-based therapeutics. we also supply several growth factor products used to increase cell culture productivity in biomanufacturing. in the burgeoning area of disposable biomanufacturing technologies, we have developed and market a series of opus™ (open platform user specified) single-use chromatography columns used in the biologics purification process. repligen’s corporate headquarters are located in waltham, ma, usa; we have an additional manufacturing facility in lund, sweden.
Repligen executives and other stock owners filed with the SEC include: